ArticleJournal of personalized medicine2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Abstract read
In one paragraph
Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of esketamine for pain control after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials.Frontiers in pharmacology · 2025Pooled it
- Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic Study.Clinics and practice · 2026Article
- Conditional Acceptance and the Optimism-Knowledge Gap: A Scoping Review of Attitudes and Perceptions of Artificial Intelligence in Healthcare in Italy.Medical sciences (Basel, Switzerland) · 2026Article
- Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal.Behavioral sciences (Basel, Switzerland) · 2026Review
- Integrating Psychiatric, Psychotherapeutic, and Nursing Care in Intranasal Esketamine for Treatment-Resistant Depression.Journal of clinical medicine · 2026Review
- Pain and Suicide Behavior in Cancer Patients: Implications for Personalized Treatment-A Systematic Review.Journal of personalized medicine · 2026Review
- Patients' Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives.Journal of clinical medicine · 2025Review
- Patient Life Engagement and Metabolic Profile Improve After Switching from First-/Second-Generation Antipsychotics to Brexpiprazole: A Real-World Study in Patients with Schizophrenia.Journal of personalized medicine · 2025Article
- Case Report: A possible association between significant dissociations after esketamine treatment and histrionic personality disorder.Frontiers in psychiatry · 2025Article
- Efficacy and safety of toludesvenlafaxine hydrochloride sustained-release tablets in depression with ineffective or partially effective initial antidepressant treatment: a single-arm, multicenter clinical study.Frontiers in psychiatry · 2025Article
- Novel and emerging anesthetic drugs for the treatments of major depression: a comprehensive review of efficacy, mechanism, and outlook.Frontiers in psychiatry · 2025Review
- Safety and efficacy of esketamine combined with propofol or ciprofol sedation for electroconvulsive therapy in patients with major depressive disorder: protocol for a randomized, double-blind, controlled trial with factorial design.Frontiers in pharmacology · 2025Article
- Effectiveness and safety of esketamine in laparoscopic surgery patients: a systematic review and meta-analysis of randomized controlled trials.Frontiers in pharmacology · 2025Article
- Effect of esketamine on postoperative pain relief and depressive status in patients with traumatic fractures.Frontiers in medicine · 2025Article
- Ketamine as a potential cognitive enhancer in neurological disorders: evidence from preclinical and clinical studies.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Marco Di NicolaDepartment of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.ORCID 0000-0001-7457-0426
Maria PepeDepartment of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.ORCID 0009-0002-7597-6916
Giacomo d'AndreaDepartment of Neurosciences, Imaging and Clinical Sciences, Università degli Studi G. d'Annunzio, 66100 Chieti, Italy.ORCID 0000-0002-6808-3960
Ilaria MarcelliDepartment of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.ORCID 0009-0001-6252-2600
Mauro PettorrusoDepartment of Neurosciences, Imaging and Clinical Sciences, Università degli Studi G. d'Annunzio, 66100 Chieti, Italy.ORCID 0000-0002-4164-3040
Ileana AndriolaDepartment of Translational Biomedicine and Neuroscience, Università degli Studi di Bari Aldo Moro, 70121 Bari, Italy.
Stefano BarlatiDepartment of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.ORCID 0000-0002-1784-3915
Matteo CarminatiMood Disorder Unit, Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Carlo Ignazio CattaneoDepartment of Mental Health, ASL Biella, 13875 Biella, Italy.ORCID 0000-0002-6930-8105
Massimo ClericiDepartment of Mental Health, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Domenico De BerardisDepartment of Mental Health, ASL 4, 64100 Teramo, Italy.ORCID 0000-0003-4415-5058
Sergio De FilippisNeuropsychiatric Clinic, Villa Von Siebenthal, 00040 Genzano di Roma, Italy.
Bernardo Dell'OssoDepartment of Biomedical and Clinical Sciences Luigi Sacco and Aldo Ravelli Center for Neurotechnology and Brain Therapeutic, Università di Milano, 20132 Milano, Italy.
Giorgio Di LorenzoChair of Psychiatry, Department of Systems Medicine, Tor Vergata, 00133 Roma, Italy.ORCID 0000-0002-0576-4064
Giuseppe MainaSan Luigi Gonzaga University Hospital, Department of Neurosciences "Rita Levi Montalcini", Università di Torino, 10125 Torino, Italy.ORCID 0000-0002-2533-140X
Mirko ManchiaUnit of Clinical Psychiatry, University Hospital Agency of Cagliari, 09123 Cagliari, Italy.ORCID 0000-0003-4175-6413
Matteo MarcatiliDepartment of Mental Health, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Vassilis MartiadisDepartment of Mental Health, ASL Napoli 1 Centro, 80145 Naples, Italy.ORCID 0000-0002-3344-1000
Cinzia NioluChair of Psychiatry, Department of Systems Medicine, Tor Vergata, 00133 Roma, Italy.
Antonino PetraliaDepartment of Clinical and Experimental Medicine, Psychiatry Unit, Università di Catania, 95123 Catania, Italy.ORCID 0000-0002-2163-1608
Gianluca RossoSan Luigi Gonzaga University Hospital, Department of Neurosciences "Rita Levi Montalcini", Università di Torino, 10125 Torino, Italy.ORCID 0000-0002-2308-9146
Gianluca SerafiniDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genova, 17100 Genova, Italy.ORCID 0000-0002-6631-856X
Maria Salvina SignorelliDepartment of Clinical and Experimental Medicine, Psychiatry Unit, Università di Catania, 95123 Catania, Italy.ORCID 0000-0002-6941-9454
Tommaso VannucchiFunctional Unit of Adults Mental Health, Mental Health Department, 59100 Prato, Italy.
Matteo VismaraDepartment of Biomedical and Clinical Sciences Luigi Sacco and Aldo Ravelli Center for Neurotechnology and Brain Therapeutic, Università di Milano, 20132 Milano, Italy.ORCID 0000-0002-9533-8615
Raffaella ZanardiMood Disorder Unit, Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0001-5941-5663
Antonio VitaDepartment of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.ORCID 0000-0002-3621-6394
Gabriele SaniDepartment of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.ORCID 0000-0002-9767-8752
Giovanni MartinottiDepartment of Neurosciences, Imaging and Clinical Sciences, Università degli Studi G. d'Annunzio, 66100 Chieti, Italy.ORCID 0000-0002-7292-2341
Real-ESKperience Study Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
artificial intelligenceglutamatergic systemmood disorderspatient perspectivepersonalized medicinepsychopharmacology
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.